Testing an HIV disclosure program for men living with HIV in Uganda
Tests a program helping men with HIV in Uganda share their status with others.
Plain-language title generated from the registry record
Registry title: Developing an HIV Disclosure Intervention for Men in Uganda
Key facts
- Where
- Mbarara, UgandaSee the site
Where in Uganda
- Mbarara University of Science and TechnologyMbarara, UgandaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Brigham and Women's Hospital
- Trial code
- NCT05771519
- Record updated
- 16 July 2026
- Original description
The goal of this clinical trial is to test an HIV disclosure intervention that the investigators are developing focused on men living with HIV in Uganda. The main questions the investigators are trying to answer is whether the HIV disclosure intervention the investigators develop will help men who receive this intervention to disclose their HIV status to a greater extent than men who receive standard care.Read full original descriptionShow less
Development and Assessment of an HIV Disclosure Intervention for Men in Uganda
The goal of this clinical trial is to test an HIV disclosure intervention that the investigators are developing focused on men living with HIV in Uganda. The main questions the investigators are trying to answer is whether the HIV disclosure intervention the investigators develop will help men who receive this intervention to disclose their HIV status to a greater extent than men who receive standard care.
Participants assigned to the intervention group will likely participate in the following:
* Sexual health education * Cognitive behavioral therapy strategies * Problem-solving skills building * Motivational interviewing * Developing a personalized HIV disclosure plan * Communication skills building * Role-playing disclosure strategies
Exclusion: an inability to speak the local language (Runyankole) or English; an inability to provide informed consent.
For all 3 Aims, "index participants" inclusion criteria will include:; men living with HIV; with sexually transmitted infection symptoms (e.g., urethral discharge, genital lesions); either not accessing antiretroviral therapy (per self-report109 and/or clinic documentation) or accessing antiretroviral therapy without HIV viral suppression; age ≥18 years,; with at least one sexual partner in the past three months; Aims 2 and 3 have the additional inclusion criteria:; men living with HIV without HIV disclosure to at least one partner; In Aims 2 and 3, male participants will be encouraged to invite sexual partners for enrollment. These "partner participants" will have the following inclusion criteria:; age ≥18 years; partnered with an enrolled man who reports HIV disclosure or plans for HIV disclosure with study support; referred by the male participant.